The latest closing stock price for Gain Therapeutics as of June 18, 2025 is 1.79.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-840 today, roughly -1 times their original investment - a -36.77% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 3.19, which is 78.2% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 50.3% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 1.81.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-840 today, roughly -1 times their original investment - a -36.77% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 3.19, which is 78.2% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 50.3% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 1.81.